Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

Conditions:   Hypertension;   Dyslipidemias Interventions:   Drug: Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination));   Drug: Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin) Sponsor:   Yonsei University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials